Cargando…

Response Modifiers: Tweaking the Immune Response Against Influenza A Virus

Despite causing pandemics and yearly epidemics that result in significant morbidity and mortality, our arsenal of options to treat influenza A virus (IAV) infections remains limited and is challenged by the virus itself. While vaccination is the preferred intervention strategy against influenza, its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elbahesh, Husni, Gerlach, Thomas, Saletti, Giulietta, Rimmelzwaan, Guus F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473099/ https://www.ncbi.nlm.nih.gov/pubmed/31031778 http://dx.doi.org/10.3389/fimmu.2019.00809

Ejemplares similares

Aging and Options to Halt Declining Immunity to Virus Infections
por: Palacios-Pedrero, Miguel Ángel, et al.
Publicado: (2021)

Influenza Virus Infections and Cellular Kinases
por: Meineke, Robert, et al.
Publicado: (2019)

Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63
por: Saletti, Giulietta, et al.
Publicado: (2020)

FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants
por: Meineke, Robert, et al.
Publicado: (2023)

Influenza Vaccines: Successes and Continuing Challenges
por: Becker, Tanja, et al.
Publicado: (2021)

FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections
por: Meineke, Robert, et al.
Publicado: (2022)

Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection
por: Kubinski, Mareike, et al.
Publicado: (2023)

ADCC: An underappreciated correlate of cross-protection against influenza?
por: de Vries, Rory D., et al.
Publicado: (2023)

Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice
por: Beicht, Jana, et al.
Publicado: (2023)

Targets for the Induction of Protective Immunity Against Influenza A Viruses
por: Bodewes, Rogier, et al.
Publicado: (2010)

A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection
por: Kubinski, Mareike, et al.
Publicado: (2023)

Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses
por: van de Sandt, Carolien E., et al.
Publicado: (2012)

Genetically diverse CC-founder mouse strains replicate the human influenza gene expression signature
por: Elbahesh, Husni, et al.
Publicado: (2016)

A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus
por: Martina, Byron E. E., et al.
Publicado: (2011)

Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise
por: Kubinski, Mareike, et al.
Publicado: (2020)

TWEAK and Fn14 in the Neurovascular Unit
por: Yepes, Manuel
Publicado: (2013)

The Role of Ubiquitination in TWEAK-Stimulated Signaling
por: Vucic, Domagoj
Publicado: (2013)

Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus
por: Gautam, Avishekh, et al.
Publicado: (2019)

Breaking Bad: Autophagy Tweaks the Interplay Between Glioma and the Tumor Immune Microenvironment
por: Fan, Yuxiang, et al.
Publicado: (2021)

T and B Cell Immune Responses to Influenza Viruses in Pigs
por: Holzer, Barbara, et al.
Publicado: (2019)

Host Immune Response to Influenza A Virus Infection
por: Chen, Xiaoyong, et al.
Publicado: (2018)

TWEAK: A New Player in Obesity and Diabetes
por: Vendrell, Joan, et al.
Publicado: (2013)

Rift Valley Fever Virus—Infection, Pathogenesis and Host Immune Responses
por: Nair, Niranjana, et al.
Publicado: (2023)

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
por: Altenburg, Arwen F., et al.
Publicado: (2014)

Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
por: Bertin, Daniel, et al.
Publicado: (2013)

Age distribution of cases caused by different influenza viruses
por: Rimmelzwaan, Guus F, et al.
Publicado: (2013)

B cell fate mapping reveals their contribution to the memory immune response against helminths
por: Haase, Paul, et al.
Publicado: (2022)

Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution
por: Honce, Rebekah, et al.
Publicado: (2019)

Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo
por: Koch, Rebecca M., et al.
Publicado: (2017)

TWEAK and LTβ Signaling during Chronic Liver Disease
por: Dwyer, Benjamin J., et al.
Publicado: (2014)

Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice
por: Wilken, Lucas, et al.
Publicado: (2023)

Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?
por: Wilken, Lucas, et al.
Publicado: (2020)

Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells
por: Driver, John P., et al.
Publicado: (2020)

Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway
por: Stock, Ariel D., et al.
Publicado: (2013)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
por: Dong, Wei, et al.
Publicado: (2018)

Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection
por: Leber, Andrew, et al.
Publicado: (2017)

Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D
por: Al-Ahdal, Mohammed N., et al.
Publicado: (2018)

Respiratory Mucosal Proteome Quantification in Human Influenza Infections
por: Marion, Tony, et al.
Publicado: (2016)

TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK
por: Carmona Arana, José Antonio, et al.
Publicado: (2014)

TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases
por: Blanco-Colio, Luis M.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vm6tmlcht67i9a561m23q19ooo